DrugDashboards

Levothyroxine Sodium

levothyroxine sodium · LEVOTHYROXINE SODIUM .05 mg/1 · Tablet · Oral · XLCare Pharmaceuticals, Inc.

NDC 72865-0237-90 · 90 TABLET in 1 BOTTLE · ANDA · View full market →

The short version

7 companies supply this market — a reasonable cushion if one runs into trouble. Historically, drugs in this position went on to a new shortage within 90 days about 0.5% of the time — roughly 3× the typical drug (0.1%).

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

One drug, every price

The same NDC has different prices depending on who is paying. Units differ between rungs — compare within a rung over time, not rung against rung, unless the units match.

ⓘ How this was built
Data sources
  • CMS NADAC (pharmacy acquisition, weekly)
  • CMS Part B ASP quarterly payment limits
  • CMS Maximum Fair Prices (IRA negotiated, NDC-level)
  • Medicare Part D Spending by Drug (data.cms.gov, name-matched)
  • VA FSS / Big4 federal contract prices (va.gov, twice monthly)
  • ACA Federal Upper Limits + weighted AMP (data.medicaid.gov, monthly)
  • California SB-17 WAC filings (list price, per package)
Method

Each rung is the newest figure for this NDC from one federal price system, shown with its own unit. Part D is matched by drug name because CMS publishes no NDCs there; it is gross spending, before confidential rebates.

Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.

  • Part D plans paid (avg)$0.0923per dosage unitgross, before rebates — matched by drug name · 2024
  • Federal contracts pay (FSS)$0.0533per unitXLCare Pharmaceuticals, Inc. · Jan 27, 2025

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

90-day shortage risk (model v2)

0.5%chance of a new FDA shortage posting for levothyroxine sodium (oral solid) in the next 90 days

16 Class I/II recall(s) in 12 months · OAI inspection at a producing facility (24 months) · sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is 3× that.

Backtested statistical model over the whole market, not this package alone. Model details →

Where it's made

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Regulatory

Application
ANDA215259
TE code
AB4
Approval date
Jan 18, 2023
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of levothyroxine sodium (Tablet)

LabelerStrengthFirst seenLast seen
A-S Medication SolutionsLEVOTHYROXINE SODIUM .088 mg/1Jul 15, 2026Sep 3, 2026
A-S Medication SolutionsLEVOTHYROXINE SODIUM 150 ug/1Jul 15, 2026Sep 3, 2026
A-S Medication SolutionsLEVOTHYROXINE SODIUM .1 mg/1Jul 15, 2026Sep 3, 2026
A-S Medication SolutionsLEVOTHYROXINE SODIUM .025 mg/1Jul 15, 2026Sep 3, 2026
A-S Medication SolutionsLEVOTHYROXINE SODIUM .137 mg/1Jul 15, 2026Sep 3, 2026
A-S Medication SolutionsLEVOTHYROXINE SODIUM 25 ug/1Jul 15, 2026Sep 3, 2026
A-S Medication SolutionsLEVOTHYROXINE SODIUM 88 ug/1Jul 15, 2026Sep 3, 2026
A-S Medication SolutionsLEVOTHYROXINE SODIUM .125 mg/1Jul 15, 2026Sep 3, 2026
A-S Medication SolutionsLEVOTHYROXINE SODIUM .075 mg/1Jul 15, 2026Sep 3, 2026
A-S Medication SolutionsLEVOTHYROXINE SODIUM 75 ug/1Jul 15, 2026Sep 3, 2026
A-S Medication SolutionsLEVOTHYROXINE SODIUM 112 ug/1Jul 15, 2026Sep 3, 2026
A-S Medication SolutionsLEVOTHYROXINE SODIUM .112 mg/1Jul 15, 2026Sep 3, 2026
A-S Medication SolutionsLEVOTHYROXINE SODIUM 125 ug/1Jul 15, 2026Sep 3, 2026
A-S Medication SolutionsLEVOTHYROXINE SODIUM .15 mg/1Jul 15, 2026Sep 3, 2026
A-S Medication SolutionsLEVOTHYROXINE SODIUM 100 ug/1Jul 15, 2026Sep 3, 2026
A-S Medication SolutionsLEVOTHYROXINE SODIUM 50 ug/1Jul 15, 2026Sep 3, 2026
A-S Medication SolutionsLEVOTHYROXINE SODIUM 200 ug/1Jul 15, 2026Sep 3, 2026
Bryant Ranch PrepackLEVOTHYROXINE SODIUM 100 ug/1Jul 15, 2026Sep 3, 2026
Bryant Ranch PrepackLEVOTHYROXINE SODIUM 125 ug/1Jul 15, 2026Sep 3, 2026
Bryant Ranch PrepackLEVOTHYROXINE SODIUM 150 ug/1Jul 15, 2026Sep 3, 2026
Bryant Ranch PrepackLEVOTHYROXINE SODIUM 112 ug/1Jul 15, 2026Sep 3, 2026
Bryant Ranch PrepackLEVOTHYROXINE SODIUM 75 ug/1Jul 15, 2026Sep 3, 2026
Bryant Ranch PrepackLEVOTHYROXINE SODIUM 200 ug/1Jul 15, 2026Sep 3, 2026
Bryant Ranch PrepackLEVOTHYROXINE SODIUM 50 ug/1Jul 15, 2026Sep 3, 2026
Bryant Ranch PrepackLEVOTHYROXINE SODIUM 88 ug/1Jul 15, 2026Sep 3, 2026
Bryant Ranch PrepackLEVOTHYROXINE SODIUM 25 ug/1Jul 15, 2026Sep 3, 2026
Bryant Ranch PrepackLEVOTHYROXINE SODIUM 300 ug/1Jul 15, 2026Sep 3, 2026
Northwind Health Company, LLCLEVOTHYROXINE SODIUM 88 ug/1Jul 15, 2026Sep 3, 2026
Northwind Health Company, LLCLEVOTHYROXINE SODIUM 50 ug/1Jul 15, 2026Sep 3, 2026
Northwind Health Company, LLCLEVOTHYROXINE SODIUM 112 ug/1Jul 15, 2026Sep 3, 2026
Northwind Health Company, LLCLEVOTHYROXINE SODIUM 175 ug/1Jul 15, 2026Sep 3, 2026
NuCare Pharmaceuticals, Inc.LEVOTHYROXINE SODIUM .075 mg/1Aug 27, 2026Sep 3, 2026
NuCare Pharmaceuticals,Inc.LEVOTHYROXINE SODIUM 50 ug/1Jul 15, 2026Sep 3, 2026
Preferred Pharmaceuticals Inc.LEVOTHYROXINE SODIUM 88 ug/1Jul 15, 2026Sep 3, 2026
Preferred Pharmaceuticals Inc.LEVOTHYROXINE SODIUM 100 ug/1Jul 15, 2026Sep 3, 2026
Preferred Pharmaceuticals Inc.LEVOTHYROXINE SODIUM 50 ug/1Jul 15, 2026Sep 3, 2026
Preferred Pharmaceuticals Inc.LEVOTHYROXINE SODIUM 25 ug/1Jul 15, 2026Sep 3, 2026
Preferred Pharmaceuticals Inc.LEVOTHYROXINE SODIUM 175 ug/1Jul 15, 2026Sep 3, 2026
Proficient Rx LPLEVOTHYROXINE SODIUM .112 mg/1Jul 15, 2026Sep 3, 2026
Proficient Rx LPLEVOTHYROXINE SODIUM 100 ug/1Jul 15, 2026Sep 3, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Levothyroxine Sodium — NDC 72865-0237-90," retrieved September 3, 2026, https://drugdashboards.com/drug/72865023790.

Free to cite with attribution — see how the data is put together.